DoW Alzheimer?s Transforming Research Award

The DoW Alzheimer’s Transforming Research Award supports research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). The award focuses on two main areas: Risk Factor Knowledge and Risk Reduction Solutions. Applications must address at least one of these focus areas and may include research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks. Clinical research is allowed, but clinical trials and animal research are prohibited. Preliminary data are required, and community collaboration is required for research prospectively enrolling human subjects. • The award includes an option for more than one PI and supports both new and existing collaborative partnerships. • The award supports transformative advancements in reducing risk and preventing AD/ADRD. • Applications must address at least one of the focus areas. • Preliminary data are required. • Community collaboration is required for research prospectively enrolling human subjects.